{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:18:07Z","timestamp":1794590287990,"version":"4.9.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ajo.2020.03.053","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T19:53:47Z","timestamp":1586548427000},"page":"91-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More"],"prefix":"10.1016","volume":"221","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7162-8116","authenticated-orcid":false,"given":"Michael","family":"Kinori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Armarnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Listernick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Charrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice Lasky","family":"Zeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2020.03.053_bib1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.7326\/0003-4819-144-11-200606060-00010","article-title":"Pathophysiology of neurofibromatosis type 1","volume":"144","author":"Theos","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajo.2020.03.053_bib2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.survophthal.2017.10.007","article-title":"Ophthalmic manifestations in neurofibromatosis type 1","volume":"63","author":"Kinori","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2020.03.053_bib3","series-title":"Neurofibromatosis: phenotype, natural history, and pathogenesis","author":"Friedman","year":"1999"},{"key":"10.1016\/j.ajo.2020.03.053_bib4","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJM199411243312102","article-title":"Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father","volume":"331","author":"Lazaro","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2020.03.053_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.21107","article-title":"Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations","volume":"61","author":"Listernick","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajo.2020.03.053_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ajo.2003.09.055","article-title":"Optic radiation involvement in optic pathway gliomas in neurofibromatosis","volume":"137","author":"Liu","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2020.03.053_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.icu.0000243016.90004.12","article-title":"Optic gliomas of the anterior visual pathway","volume":"17","author":"Liu","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajo.2020.03.053_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/08820530701745223","article-title":"Neurofibromatosis type I: genetics and clinical manifestations","volume":"23","author":"Savar","year":"2008","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.ajo.2020.03.053_bib9","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ophtha.2003.06.008","article-title":"Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients","volume":"111","author":"Thiagalingam","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2020.03.053_bib10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0002-9394(00)00852-7","article-title":"Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging","volume":"131","author":"Balcer","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2020.03.053_bib11","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0022-3476(95)70159-1","article-title":"Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history","volume":"127","author":"Listernick","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajo.2020.03.053_bib12","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1200\/JCO.2003.03.043","article-title":"Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology","volume":"21","author":"Laithier","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajo.2020.03.053_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ajmg.a.20211","article-title":"Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome","volume":"122-A","author":"King","year":"2003","journal-title":"Am J Med Genet A"},{"issue":"21 suppl1","key":"10.1016\/j.ajo.2020.03.053_bib14","first-page":"S15","article-title":"Functional outcome measures for NF1-associated optic pathway glioma clinical trials","volume":"81","author":"Fisher","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ajo.2020.03.053_bib15","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00330-004-2433-y","article-title":"Pediatric brain MRI in neurofibromatosis type I","volume":"15","author":"Mentzel","year":"2005","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ajo.2020.03.053_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/COC.0b013e3182467efa","article-title":"Optic glioma in children: a retrospective analysis of 101 cases","volume":"36","author":"Varan","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ajo.2020.03.053_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaapos.2009.11.020","article-title":"Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients","volume":"14","author":"Segal","year":"2010","journal-title":"J AAPOS"},{"key":"10.1016\/j.ajo.2020.03.053_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11060-016-2163-4","article-title":"Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1","volume":"129","author":"Wan","year":"2016","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ajo.2020.03.053_bib19","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1002\/cncr.29649","article-title":"Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive","volume":"121","author":"Dodgshun","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ajo.2020.03.053_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/pbc.24726","article-title":"Visual acuity of children treated with chemotherapy for optic pathway gliomas","volume":"61","author":"Kalin-Hajdu","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ajo.2020.03.053_bib21","first-page":"575","article-title":"Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference","volume":"45","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ajo.2020.03.053_bib22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/archneurpsyc.1958.02340060003001","article-title":"Gliomas of the optic nerves","volume":"79","author":"Dodge","year":"1958","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"10.1016\/j.ajo.2020.03.053_bib23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/archopht.120.3.268","article-title":"A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children","volume":"120","author":"Pediatric Eye Disease Investigator","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2020.03.053_bib24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/neuonc\/nos076","article-title":"Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis","volume":"14","author":"Fisher","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ajo.2020.03.053_bib25","first-page":"1114","article-title":"Prognostic significance of type 1 neurofibromatosis (von Recklinghausen disease) in childhood optic glioma","volume":"38","author":"Deliganis","year":"1996","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ajo.2020.03.053_bib26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s004310000531","article-title":"When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients\u00a0treated in a single centre","volume":"159","author":"Grill","year":"2000","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ajo.2020.03.053_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00041327-200103000-00001","article-title":"Long-term visual outcome in patients with anterior visual pathway gliomas","volume":"21","author":"Gayre","year":"2001","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ajo.2020.03.053_bib28","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/pbc.22198","article-title":"Natural history and outcome of optic pathway gliomas in children","volume":"53","author":"Nicolin","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ajo.2020.03.053_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pediatrneurol.2017.06.019","article-title":"Clinical presentation and outcome of patients with optic pathway glioma","volume":"75","author":"Robert-Boire","year":"2017","journal-title":"Pediatr Neurol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939420301653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939420301653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:43:51Z","timestamp":1757598231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939420301653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":29,"alternative-id":["S0002939420301653"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2020.03.053","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2020.03.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}